Clinical trial · Interventional
the Safety and Effectiveness of Protein Supplements on Cancer Patients With Nutritional Risk and Malnutrition
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Nutritional risk and malnutrition is common in cancer patients, which is one of the significant factors affecting the overall survival, toxicity during anticancer treatment, and quality of life among patients with cancer. Previous studies have shown that the increased protein intake can stimulate muscle synthesis, and improve muscle mass, strength, function, overall survival, and quality of life. The current study is going to investigate the effectiveness and safety of protein supplements on patients with cancer, in order to provide a reference for further nutrition treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Malnutrition | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| nutrition counseling | Behavioral | — | UNRESOLVED |
| protein supplement | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- protein supplements
- description
- This group will receive dietary guidance and protein supplements for 3 months
- interventionNames
- Dietary Supplement: protein supplement
- Behavioral: nutrition counseling
- type
- OTHER
- label
- dietary guidance
- description
- this group will receive dietary guidance for 3 months
- interventionNames
- Behavioral: nutrition counseling
Primary outcomes (3)
- measure
- blood toxicity
- timeFrame
- 6 month
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * • Age\>=18years old; * Initial treatment patients with lung/gastrointestinal/esophageal cancer * Patients with nutritional risk (NRS-2002≥3) ; * Patients are able to provide written informed consent. Exclusion Criteria: * • People who are allergic to whey protein. * Participants received any drugs or supplements known to influence the outcomes, such as protein powder, anabolic steroids, or glucocorticoids before the 3 months preceding the study. * Participants with gastrointestinal bleeding or intestinal obstruction, or any contraindication for oral intake * Concurrent severe cardiac disease, liver and renal failure, which may significantly interfere with study compliance. * Participants with electronic or mental device. * Women in pregnancy or lactation period
References
Publications (0)
Data not yet available